Liver Diseases, Alcoholic: all 74 studies
Page 1 of 1. Open to participants first (25), then studies with results posted, then the rest; newest registration first within each.
- Study to Evaluate ALN-CIDEB in Adults With Fibrotic Alcohol-Associated Liver Disease (ALD)Not yet recruitingNCT07933328Phase 2
- A Study to Investigate the Safety and Efficacy of Efimosfermin Alfa Compared With Placebo in Adult Participants With Alcohol-related Liver Disease (ALD)RecruitingNCT07791043Phase 2
- Elastography-based Brief Alcohol Intervention in Hospitalized IndividualsRecruitingNCT07637539Not applicable
- Personalized Transcranial Magnetic Stimulation (TMS) for Metabolic Dysfunction and Alcohol-Related Liver DiseaseNot yet recruitingNCT07399600Not applicable
- Health Literacy and Self-efficacy Expectations in Patients With Alcohol-related Liver CirrhosisRecruitingNCT07169526
- Long-term Follow-up to Determine Outcome in Liver Disease (LOVE Study)Not yet recruitingNCT06907563
- A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver DiseaseRecruitingNCT06613698Phase 2
- Alcohol Misuse Treatment to Patients Newly Diagnosed With Alcohol-related Liver Disease: a Randomized Controlled TrialRecruitingNCT06493773Not applicable
- Intra-Hepatic Microbiota in Alcoholic HepatitisRecruitingNCT06307964
- MRG-001 in Patients With Alcoholic HepatitisNot yet recruitingNCT06307522Phase 2
- French National MICMAF CohortRecruitingNCT05895890
- The Liver Care TrialRecruitingNCT05855031Not applicable
- Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic PatientsRecruitingNCT05699018Not applicable
- Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY)Not yet recruitingNCT05473325
- Study of HMB-enriched Amino Acid Supplementation in Patients With Alcoholic Liver Disease and COVID-19RecruitingNCT04858412Not applicable
- Integrated Diagnostics for Early Diagnosis of Liver DiseaseRecruitingNCT04666402
- Study of Alcohol-related Liver Disease in EuropeRecruitingNCT04400604
- Effect of Fermented Protaetia Brevitarsis Seulensis Powder on Alcohol-induced Liver DiseaseRecruitingNCT04320199Not applicable
- Cohort/Ethics Study of Patients With Severe Alcoholic Hepatitis Undergoing Early Liver TransplantationEnrolling by invitationNCT04234139
- Study of Genetic Determinants in Alcoholic Hepatitis and Establishment of a Multicenter Prospective Cohort of Patients With Alcoholic Liver DiseaseRecruitingNCT04106518
- Herbal Supplements for Improvement of Liver Function in Participants With Alcoholic Liver DiseaseNot yet recruitingNCT03503708Not applicable
- Screening At-risk Populations for Hepatic Fibrosis With Non-invasive MarkersRecruitingNCT03308916Not applicable
- Evaluating Alcohol Use in Alcoholic Liver DiseaseRecruitingNCT03267069
- Comparison of ALD, NASH, and Healthy Control PatientsRecruitingNCT03224949
- Ethanol Induces Skeletal Muscle AutophagyRecruitingNCT03209791
- BRIDGE Device for Post-operative Pain ControlTerminatedNCT03265249Not applicableResults posted
- Clinical Study In Infants With Rapidly Progressive Lysosomal Acid Lipase DeficiencyTerminatedNCT02193867Phase 2Results posted
- Effect of Probiotics on Gut-Liver Axis of Alcoholic Liver DiseaseCompletedNCT01501162Phase 4Results posted
- Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Sebelipase Alfa in Children With Growth Failure Due to Lysosomal Acid Lipase DeficiencyCompletedNCT01371825Phase 2/3Results posted
- Effects of SAMe in Patients With Alcoholic Liver DiseaseCompletedNCT00573313Phase 3Results posted
- CM for Patients With ALD After Liver TransplantCompletedNCT06304467Not applicable
- Granulocyte Colony Stimulating Factor Four Week Plus N-Acetyl Cysteine in Severe Alcoholic HepatitisCompletedNCT05840640Phase 4
- Gut Mycobiome Profile in Alcoholic Liver Disease.Status unknownNCT05793190
- Advanced Chronic Liver Disease Screening by Transient Elstography in Patients Hospitalised in a Psychiatric UnitCompletedNCT05602870Not applicable
- Alcohol, Gut Leakiness, & Liver DiseaseCompletedNCT05428072Early Phase 1
- Integrating Care for Patients With Alcohol Liver Disease and Alcohol Use DisordersCompletedNCT05375682Not applicable
- Prognostic Factors After Liver TransplantationCompletedNCT05018741
- Alcoholic Liver Disease and the Gut MicrobiomeActive, not recruitingNCT05007470Not applicable
- Impact of Integrating an Addiction Team on Post Liver Transplantation Survival for Alcohol-related Liver Disease and Its Complications.CompletedNCT04964687
- Guselkumab (Anti-IL 23 Monoclonal Antibody) for Alcohol Associated Liver DiseaseCompletedNCT04736966Phase 1
- Cognitive Function of Alcoholic Compensated Liver CirrhosisCompletedNCT04557774
- Early Detection of Alcoholic Liver DiseaseWithdrawnNCT04070508
- S-adenosylmethionine Plus Choline in Treatment of Patients With Alcoholic Liver DiseaseStatus unknownNCT03938662Not applicable
- DUR-928 in Patients With Alcoholic HepatitisCompletedNCT03917407Phase 2
- Integrated Approaches for Identifying Molecular Targets in Liver DiseaseCompletedNCT03915002
- Profermin®: Prevention of Progression in Alcoholic Liver Disease by Modulating Dysbiotic MicrobiotaActive, not recruitingNCT03863730Not applicable
- Value on Survival of Liver Volume After an Acute Decompensation of an Alcoholic CirrhosisTerminatedNCT03508388
- Text Messaging to Reduce Alcohol Relapse in Liver Transplant PatientsCompletedNCT03402256Not applicable
- Using Addiction Comprehensive Health Enhancement Support System (ACHESS) in an Alcoholic Liver Disease PopulationStatus unknownNCT03388320Not applicable
- Stratification of Chronic Alcoholic Liver Diseases (SCALE Study)Status unknownNCT03295812
- Quantitative MRI for Non-invasive Assessment of Severity of Alcoholic Liver Disease (ALD)Active, not recruitingNCT03113929
- G-CSF Plus NAC In Severe Alcoholic HepatitisStatus unknownNCT02971306Phase 4
- Meta-Analysis of Drug Therapy in Patients With Severe Alcoholic HepatitisCompletedNCT02796469
- THE IMMUNOLOGICAL EFFECTS AND METABOLIC TOLERANCE OF LIPID INFUSION IN PATIENTS WITH CIRRHOSIS.CompletedNCT02381769Not applicable
- Effect of Probiotics on Gut-Liver Axis of Alcoholic HepatitisStatus unknownNCT02335632Phase 4
- RCT Study on Granulocyte Colony-stimulating Factor(G-CSF) Treatment of Hepatic FailureStatus unknownNCT02331745Phase 4
- Gastric- Versus Jejunal Feeding Tubes in Alcoholic Liver DiseasesCompletedNCT02319252Not applicable
- Efficacy of Antibiotic Therapy in Severe Alcoholic Hepatitis Treated With PrednisoloneCompletedNCT02281929Phase 3
- Long Term Effect of Aggressive Nutritional Management on Survival in Patients With Alcoholic Liver DiseaseCompletedNCT02140294Not applicable
- Transient Elastography in the Determination of Advanced Fibrosis in Alcoholic Liver Disease.CompletedNCT01789008Not applicable
- Baclofen in the Treatment of Alcohol Dependence With or Without Alcoholic Liver DiseaseCompletedNCT01711125Phase 3
- Biomarkers for the Prognosis of Decompensated Alcoholic Liver DiseaseCompletedNCT01701687
- A Novel Pharmacotherapy for Alcoholism and Alcohol Liver DiseaseCompletedNCT01504295Phase 2
- Integrated Stepped Care for Unhealthy Alcohol Use in HIVCompletedNCT01410123Not applicable
- Multicentre Prospective Cohort Study of Patients With Chronic Alcoholic and/or Metabolic Liver DiseaseCompletedNCT01237574
- Double-blind Randomized Controlled Trial in Severe Alcoholic HepatitisCompletedNCT01214226Phase 3
- Sulfation of Bile Acids as a Biomarker for Hepatobiliary DiseasesTerminatedNCT01200082
- Role of CCL2 in Alcoholic Liver DiseasesCompletedNCT01128010
- Influence of Adiponutrin in Chronic Liver DiseaseCompletedNCT01122797
- Effect of Candesartan in Alcoholic Liver FibrosisCompletedNCT00990639Phase 1/2
- Treatment of Severe Alcoholic Hepatitis With Corticoids Plus N Acetyl Cysteine Versus Corticoids AloneCompletedNCT00863785Phase 3
- sgp130 in Chronic Human Liver DiseaseCompletedNCT00770198
- FIBROSCAN Validation and Interest of Fibrotest - FIBROSCAN Association for Fibrosis Diagnosis in Alcoholic Liver DiseaseCompletedNCT00708617
- Study of T Cell Phenotype Activation Pathway in Human Alcoholic Liver DiseaseCompletedNCT00610597